BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 20524448)

  • 1. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
    Suprasert P; Khunamornpong S
    J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
    Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
    Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine carcinosarcoma in association with tamoxifen therapy.
    McCluggage WG; McManus DT; Lioe TF; Hill CM
    Br J Obstet Gynaecol; 1997 Jun; 104(6):748-50. PubMed ID: 9197885
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
    Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
    Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcomas in breast cancer patients treated with tamoxifen.
    Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
    Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine carcinosarcoma in association with tamoxifen therapy.
    Oláh KS
    Br J Obstet Gynaecol; 1997 Dec; 104(12):1420. PubMed ID: 9422027
    [No Abstract]   [Full Text] [Related]  

  • 11. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
    Okada DH; Rowland JB; Petrovic LM
    Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.
    Raspollini MR; Mecacci F; Paglierani M; Marchionni M; Taddei GL
    Pathol Res Pract; 2005; 201(2):141-4. PubMed ID: 15901136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-induced growth of leiomyomas. A case report.
    Kang J; Baxi L; Heller D
    J Reprod Med; 1996 Feb; 41(2):119-20. PubMed ID: 8656411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.